Increased Time in Range with Ultra Rapid Lispro Treatment in Participants with Type 2 Diabetes: PRONTO-Time in Range

INTRODUCTION: To evaluate time in range metrics and HbA1c in people with type 2 diabetes (T2D) treated with ultra rapid lispro (URLi) using continuous glucose monitoring (CGM) for the first time in this population. METHODS: This was a Phase 3b, 12-week, single-treatment study in adults with T2D on b...

Descripción completa

Detalles Bibliográficos
Autores principales: Bailey, Timothy S., Bode, Bruce W., Wang, Qianqian, Knights, Alastair W., Chang, Annette M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10081815/
https://www.ncbi.nlm.nih.gov/pubmed/37029268
http://dx.doi.org/10.1007/s13300-023-01400-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10081815/
https://www.ncbi.nlm.nih.gov/pubmed/37029268
http://dx.doi.org/10.1007/s13300-023-01400-w

Ejemplares similares